title: Hepatotoxicity following cyclophosphamide treatment in a patient with MPO-ANCA vasculitis.
authors: M
authors: M
authors: Martínez-Gabarrón
authors: R
authors: R
authors: Enríquez
authors: A E
authors: AE
authors: Sirvent
authors: M
authors: M
authors: García-Sepulcre
authors: I
authors: I
authors: Millán
authors: F
authors: F
authors: Amorós
mesh_terms: D000208:Acute Disease; D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002769:Cholelithiasis / Q000150:complications; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology / Q000628:therapy; D014890:Granulomatosis with Polyangiitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced*; D009195:Peroxidase / Q000276:immunology; D010956:Plasmapheresis; D006435:Renal Dialysis
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D001324:Autoantigens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D009195:Peroxidase